These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 16730454)

  • 21. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of the natural killer cell repertoire: the sequential vs. the two-step selection model.
    Salmon-Divon M; Höglund P; Mehr R
    Bull Math Biol; 2003 Mar; 65(2):199-218. PubMed ID: 12675329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.
    Bottino C; Moretta L; Pende D; Vitale M; Moretta A
    Mol Immunol; 2004 Jul; 41(6-7):569-75. PubMed ID: 15219995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells.
    Olcese L; Cambiaggi A; Semenzato G; Bottino C; Moretta A; Vivier E
    J Immunol; 1997 Jun; 158(11):5083-6. PubMed ID: 9164921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-MHC ligands for inhibitory immune receptors: novel insights and implications for immune regulation.
    Lebbink RJ; Meyaard L
    Mol Immunol; 2007 Mar; 44(9):2153-64. PubMed ID: 17188357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cell recognition by natural killer cells.
    Long EO
    Semin Cancer Biol; 2002 Feb; 12(1):57-61. PubMed ID: 11926413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor.
    Morel E; Bellón T
    Allergy; 2007 Feb; 62(2):190-6. PubMed ID: 17298429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL; Barber MA; Barber A; Zhang T
    Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenetics of killer cell immunoglobulin-like receptors.
    Parham P
    Mol Immunol; 2005 Feb; 42(4):459-62. PubMed ID: 15607799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
    J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation.
    Wang H; Ruan Z; Wang Y; Han J; Fu X; Zhao T; Yang D; Xu W; Yang Z; Wang L; Chen Y; Wu Y
    Mol Immunol; 2008 Mar; 45(6):1548-56. PubMed ID: 18062910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do NK-cell receptors and alloreactivity affect solid organ transplantation?
    Vilches C; Parham P
    Transpl Immunol; 2006 Dec; 17(1):27-30. PubMed ID: 17157210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
    Kumar V; McNerney ME
    Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
    Raja Gabaglia C; Diaz de Durana Y; Graham FL; Gauldie J; Sercarz EE; Braciak TA
    Cancer Res; 2007 Mar; 67(5):2290-7. PubMed ID: 17332360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome.
    Pyzik M; Kielczewska A; Vidal SM
    Semin Immunol; 2008 Dec; 20(6):331-42. PubMed ID: 18948016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy.
    Weiss L; Reich S; Mandelboim O; Slavin S
    Bone Marrow Transplant; 2004 Jun; 33(11):1137-41. PubMed ID: 15077128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Licensing of natural killer cells by self-major histocompatibility complex class I.
    Yokoyama WM; Kim S
    Immunol Rev; 2006 Dec; 214():143-54. PubMed ID: 17100882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.